Visual Performance Comparison Between Enhanced Monofocal and Extended Depth of Focus Intraocular Lenses: A Systematic Review and Meta-Analysis

作者
Danai Barpaki,Diamantis D. Almaliotis,Sofia N. Androudi,Konstantinos T. Tsaousis,Ioannis Tsinopoulos
出处
期刊:Cureus [Cureus, Inc.]
卷期号:18 (2): e103841-e103841 被引量:1
标识
DOI:10.7759/cureus.103841
摘要

The objective of this systematic review is to directly compare enhanced monofocal and extended depth of focus (EDOF) intraocular lenses (IOLs) with respect to visual outcomes after cataract surgery. MEDLINE, CENTRAL, clinicaltrials.gov and ICTRP were searched until April 1, 2025, to retrieve studies that compared postoperative outcomes between enhanced monofocal and EDOF IOLs. The search was based on prespecified criteria for patients, intervention, comparator, outcomes and study type. The outcomes in question were uncorrected and corrected distance, intermediate and near visual acuities, and subjective glare and halo perception. The Cochrane risk of bias tool (RoB 2) was used for risk of bias assessment for randomized studies, while the Joanna Briggs Institute (JBI) critical appraisal tool was used for risk of bias assessment for non-randomized studies. Random-effects meta-analysis was performed for uncorrected and corrected distance visual acuity. Five studies with a total of 672 eyes were included: one randomized study, one prospective comparative case control study, one retrospective comparative study and two prospective comparative case series. All studies directly compared enhanced monofocal with EDOF IOLs. Tecnis Eyhance was the enhanced monofocal IOL in all studies, while the EDOF lenses included Tecnis Symfony in three studies, Tecnis PureSee in one study and Acrysof IQ Vivity in one study. The meta-analysis that was performed for uncorrected and corrected distance visual acuity showed that there was no significant clinical difference between the two types of IOLs (mean difference: -0.01 (-0.03, -0.00), 95% CI and -0.01 (-0.02, -0.00), 95% CI, respectively). The results of individual studies pertaining to the rest of the outcomes (uncorrected and distance corrected intermediate visual acuity, uncorrected and distance corrected near visual acuity, subjective glare and halo perception) were also presented. Intermediate visual acuity improvement via cataract surgery is of particular interest contemporarily. A quantitative synthesis regarding this outcome was not feasible due to substantial heterogeneity (I2 > 50%), making meta-analysis inappropriate for this endpoint. Prevalence of non-randomized studies and different EDOF designs may have contributed to heterogeneity. Further research should be carried out.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
九月廿廿九完成签到,获得积分10
1秒前
中而且自律h完成签到,获得积分10
1秒前
2秒前
希望天下0贩的0的应助被2877采纳,获得10
2秒前
小蘑菇的应助被科研F5采纳,获得10
2秒前
搜集达人的应助被Christina采纳,获得10
2秒前
领导范儿的应助被贤惠的千雁采纳,获得10
3秒前
4秒前
4秒前
mit完成签到 ,获得积分10
4秒前
4秒前
zzz完成签到,获得积分10
5秒前
6秒前
6秒前
Hello的应助被憨憨采纳,获得10
7秒前
8秒前
8秒前
赤凰太一完成签到 ,获得积分10
10秒前
科研助理795的应助被xixi采纳,获得10
10秒前
科研F5发布了新的文献求助10
10秒前
胖崽胖崽完成签到,获得积分10
10秒前
toki发布了新的文献求助10
10秒前
11秒前
12345完成签到 ,获得积分10
11秒前
12秒前
初景的应助被霍则风采纳,获得20
12秒前
13秒前
13秒前
13秒前
要减肥小刺猬完成签到,获得积分10
13秒前
14秒前
无花果的应助被搬砖盖房采纳,获得10
15秒前
15秒前
害羞白云发布了新的文献求助10
16秒前
xinluli完成签到,获得积分10
16秒前
寄雨云中梦完成签到,获得积分10
16秒前
16秒前
njebcuiebvjc发布了新的文献求助10
18秒前
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Représentation chimique de la structure des kérogènes et des asphaltènes en fonction de leur origine et de leur degré d'évolution 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Ecotourism 400
Genera Orchidacearum Volume 4: Epidendroideae 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8062958
求助须知:如何正确求助?哪些是违规求助? 9486574
关于积分的说明 21336296
捐赠科研通 7631214
什么是DOI,文献DOI怎么找? 3396752
关于科研通互助平台的介绍 2527107
邀请新用户注册赠送积分活动 2434777